Authors
Latest:
Artificial intelligence is the new ghost author in urological research“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.
Latest:
Acute-care urology during the pandemic: Lessons learned"The goal of this narrative is to share details and lessons learned during our on-call urology coverage in the midst of the current pandemic so we can help others by informing planning," write Alexander Small, MD, and Rich Matulewicz, MD.
Latest:
Active Surveillance in Muscle Invasive Bladder CancerTypes of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.
Latest:
Addition to avelumab to best supportive care after firstline chemo improves OS in advanced urothelial CaAvelumab (Bavencio) as a maintenance treatment after chemotherapy significantly extended overall survival in patients with advanced urothelial cancer, according to findings from thephase III JAVELIN Bladder 100 trial.
Latest:
Management of UTUC using a kidney-sparing approachAdvances in endourology have made kidney-sparing treatments a viable treatment option.
Latest:
Jason Hafron, MD, predicts coming advancements in bladder cancer“[There’s] a lot going on in bladder cancer in the non–muscle invasive, muscle-invasive space, as well as in some of the biomarkers, which is exciting and will definitely have a huge impact on the management of your patients," says Jason M. Hafron, MD, CMO.
Latest:
Robotics in GU oncology: Current status, future directionsThe breadth of applications will widen as the number of new platforms grows, according Joshua Calvert, MD, MPH.
